Cognitive impairment in schizophrenia: Its impact on social functioning

Acta Psychiatrica Scandinavica, Supplement

Volumn 101, Issue 400, 2000, Pages 11-16

  Liddle, Peter F ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Brain; Cognition disorders; Regional blood flow; Schizophrenia; Social interaction

Indexed keywords

DOPAMINE RECEPTOR BLOCKING AGENT;

ALERTNESS; BRAIN BLOOD FLOW; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; HUMAN; PERFORMANCE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; SCHIZOPHRENIA; SKILL; SOCIAL INTERACTION; VERBAL MEMORY; WORKING MEMORY; ARTICLE; BLOOD FLOW; BRAIN; CHRONIC DISEASE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; PHYSIOLOGY; SOCIAL ISOLATION; VASCULARIZATION;

BRAIN; CHRONIC DISEASE; COGNITION DISORDERS; DOPAMINE ANTAGONISTS; HUMANS; REGIONAL BLOOD FLOW; SCHIZOPHRENIA; SOCIAL ALIENATION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033997509     PISSN: 00651591     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. 1. CORNBLATT RA, ERLENMEYER-KIMLING L. Global attentional deviance as a marker of risk for schizophrenia. J Abnorm Psychol 1985;96:470-86.
2. 2. JONES P, RODGERS B, MURRAY R, MARMOT M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 1994;344:1398-1402.
3. 3. DONE DJ, CROW TJ, JOHNSTONE EC, SACKER A. Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ 1994;309:699-703.
4. 4. BYRNE M, HODGES A, GRANT E, JOHNSTONE EC. Neuropsychological assessment of a group of individuals at high risk for schizophrenia and controls. Schizophr Res 1998;29:55.
5. 5. BURGESS PW, SHALLICE T. Response suppression, initiation and strategy use following frontal lobe lesions. Neuropsychologia 1996;34:263-272.
6. 6. WILSON B, COCKBURN J, BADDELEY AD, HIORNS R. The development and validation of a test battery for detecting and monitoring everyday memory problems. J Clin Exp Neuropsychol 1989;11:855-870.
7. 7. BYRNE M, HODGES A, GRANT E, JOHNSTONE EC. Evidence for executive dysfunction in young people at high genetic risk for schizophrenia. Results of the Hayling sentence completion test. Schizophr Res 1998;29:43.
8. 8. LUBIN A, GIESEKING GF, WILLIAMS HL. Direct measurement of cognitive deficit in schizophrenia. J Consult Psychol 1962;26:139-143.
9. 9. KLONOFF H, HUTTON GH, FIBIGER HC. Neuropsychological patterns in chronic schizophrenia. J Nerv Ment Dis 1970; 150:291-300.
10. 10. GREEN MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996;153:321-330.
11. 11. LIDDLE PF. The symptoms of chronic schizophrenia: a re-examination of the positive-negative dichotomy. Br J Psychiatry 1987;151:145-151.
12. 12. LEWIS SW. Computerised tomography in schizophrenia 15 years on. Br J Psychiatry 1990;157(Suppl 9):16-24.
13. 13. LIDDLE PF, FRISTON KJ, FRITH CD, JONES T, HIRSCH SR, FRACKOWIAK RSJ. Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 1992;160:179-186.
14. 14. FRITH CD, FRISTON KJ, HEROLD S et al. Regional brain activity in chronic schizophrenic patients during the performance of a verbal fluency task. Br J Psychiatry 1995; 167:343-349.
15. 15. LIDDLE PF, PASSMORE M, FRISTON KJ, FRITH CD. Functional connectivity during word generation in schizophrenia. Schizophr Res 1997;24:168.
16. 16. KEEFE R, SILVA SG, PERKINS DO, LIEBFRMAN JA. The effects of atypical antipsychotics on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr Bull 1999;25:201-222.
17. 17. GREEN MF, MARSHAL BD, WIRSCHING WC et al. Does risperidone improve working memory in treatment-resistant schizophrenia? Am J Psychiatry 1997;154:799-804.